Categories: News

Sandstone Easydrip Plus Pen Needles Debut in Turkey — PatentProtected Hexagonal Hub for Comfort and Control

Large‑platform hexagonal hub (Hextra Tech) offers superior stability and ease of grip; ISO 13485 & CE certified; launched by a leading regional diabetes distributor and 4,000+ pharmacies

- Advertisement -

ISTANBUL, Oct. 11, 2025 /PRNewswire/ — Sandstone Medical — a SteriLance Medical sub‑brand focused on diabetes self‑injection — today announced the introduction of its Easydrip™ Plus pen needles into the Turkish market through a leading regional diabetes distributor with a nationwide pharmacy network. The launch is already unlocking interest from neighbouring Middle‑East markets.

- Advertisement -

Key advantages

- Advertisement -
  • Hextra Tech hexagonal hub — a broad, six‑facet platform that helps patients keep the pen steady during insertion, reducing wobble, bruising and needle bending versus conventional narrow‑hub pen needles.
  • Greater dosing confidence — the enlarged contact surface promotes a consistent injection angle, supporting accurate sub‑cutaneous delivery.
  • Thin‑wall cannula with silicone lubrication — minimises penetration force and shortens injection time for a gentler daily routine.

Market relevance

- Advertisement -

As the first pen needle with a patent‑protected hexagonal hub available in Turkey, Easydrip™ Plus is already attracting interest from neighbouring countries and sets a practical alternative between premium global brands and low‑end generics.

- Advertisement -

Availability & next steps

- Advertisement -
  • Current channel: nationwide community pharmacies, often bundled with blood‑glucose meters.
  • Planned expansion: influencer‑driven digital campaigns and e‑commerce to reach online‑first consumers across Turkey and neighbouring states.

Certifications

- Advertisement -

Easydrip™ Plus is manufactured under a strict ISO 13485 quality system and holds CE Declaration of Conformity, meeting international safety and performance standards.

- Advertisement -

Brand Relationship

- Advertisement -

Sandstone Medical is SteriLance Medical’s diabetes‑care brand focused on self‑injection. Easydrip™ products are developed and marketed by Sandstone, with SteriLance providing manufacturing and quality systems under ISO 13485.

- Advertisement -

About Sandstone and SteriLance Medical

- Advertisement -

Sandstone designs patient‑centric solutions that make daily injections steadier and more comfortable. Founded in 1993, SteriLance Medical is a global innovator in blood‑sampling and injection solutions with 200+ patents and distribution in 50+ countries.
More information: en.sandstonemed.com | en.sterilance.com 
Media & distribution enquiries: smu@sterilance.com 

- Advertisement -

Photo – https://mma.prnewswire.com/media/2794048/Bridging_gap_premium_low_end_options__advanced_large_platform_design__ISO_13485.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/sandstone-easydrip-plus-pen-needles-debut-in-turkey–patentprotected-hexagonal-hub-for-comfort-and-control-302581334.html

- Advertisement -

Recent Posts

From Checks to Systems: Regula Recognized Across Key Layers of Identity Verification in 2026 Cybersecurity Excellence Awards

RESTON, Va., April 07, 2026 (GLOBE NEWSWIRE) -- Identity verification (IDV) is shifting from a…

1 hour ago

Naitiv Launches as the First AI-Native ServiceNow Consultancy

Founded by longtime ServiceNow leaders from Thirdera, the firm launches with acquisitions and a strategic…

1 hour ago

IP Strategy Highlights Arias Frontline K-Pop Release with RESCENE on Story

GIG HARBOR, Wash., April 07, 2026 (GLOBE NEWSWIRE) -- IP Strategy Holdings, Inc. (Nasdaq: IPST)…

1 hour ago

Emergent BioSolutions Launches New NARCAN Nasal Spray Carrying Case and Multipacks Alongside College Campus Outreach to Expand Opioid Overdose Preparedness

GAITHERSBURG, Md., April 07, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced…

1 hour ago

NextCure Receives Fast Track Designation for SIM0505 (CDH6 ADC) in Ovarian Cancer

April 07, 2026 08:05 ET  | Source: NextCure The U.S. Food and Drug Administration (FDA)…

1 hour ago

Valitor Announces Oral Presentation at the Upcoming Association for Research in Vision and Ophthalmology (ARVO) 2026 Annual Meeting

April 07, 2026 08:00 ET  | Source: Valitor, Inc. BERKELEY, Calif., April 07, 2026 (GLOBE NEWSWIRE)…

1 hour ago